CONCISE MEDICO LIMITED iXBRL

CONCISE MEDICO LIMITED

Annual Report and Financial Statements

for the financial year ended 26 December 2024

CONCISE MEDICO LIMITED

DIRECTORS AND OTHER INFORMATION


Directors	Mr Qamar Zaman
	Mr Kamran Khatana


Company Registration Number	08321341


Registered Office and Business Address	Daisyfield Mill Appleby Street
	Blackburn
	Lancashire
	BB1 3BL
	United Kingdom


Independent Auditors	Sterling Cooper Consultants Ltd
	Kings Court 33 King Street
	Lancashire
	BB2 2DH
	United Kingdom

CONCISE MEDICO LIMITED

DIRECTORS' REPORT

for the financial year ended 26 December 2024

The directors present their report and the audited financial statements for the financial year ended 26 December 2024.

Principal Activity

The principal activity of the company during the year continued to be the provision of legal services.

Directors

The directors who served during the financial year are as follows:

Mr Qamar Zaman

Mr Kamran Khatana

There were no changes in shareholdings between 26 December 2024 and the date of signing the financial statements.

In accordance with the Constitution, the directors retire by rotation and, being eligible, offer themselves for re-election.

Political Contributions

The company did not make any disclosable political donations in the current financial year.

Statement of Directors' Responsibilities

The directors are responsible for preparing the Directors' Report and the financial statements in accordance with applicable law and regulations.

Company law requires the directors to prepare financial statements for each financial year. Under that law the directors have elected to prepare the financial statements in accordance with United Kingdom Generally Accepted Accounting Practice (United Kingdom Accounting Standards and applicable law) including FRS 102 “The Financial Reporting Standard applicable in the UK and Republic of Ireland”. Under company law the directors must not approve the financial statements unless they are satisfied that they give a true and fair view of the state of affairs of the company and of the profit or loss of the company for that period. In preparing these financial statements, the directors are required to:

-select suitable accounting policies and apply them consistently;

-make judgements and accounting estimates that are reasonable and prudent;

-prepare the financial statements on the going concern basis unless it is inappropriate to presume that the company will continue in business.

The directors are responsible for keeping adequate accounting records that are sufficient to show and explain the company's transactions and disclose with reasonable accuracy at any time the financial position of the company and enable them to ensure that the financial statements comply with the Companies Act 2006. They are also responsible for safeguarding the assets of the company and hence for taking reasonable steps for the prevention and detection of fraud and other irregularities.

Disclosure of Information to Auditor
Each persons who are directors at the date of approval of this report confirms that:
In so far as the directors are aware:
-there is no relevant audit information (information needed by the company's auditor in connection with preparing the auditor's report) of which the company's auditor is unaware, and
-the directors have taken all the steps that they ought to have taken to make themselves aware of any relevant audit information and to establish that the company's auditor is aware of that information.

Auditors

The auditors, Sterling Cooper Consultants Ltd have indicated their willingness to continue in office in accordance with the provisions of Section 485 of the Companies Act 2006.

Special provisions relating to small companies

The above report has been prepared in accordance with the special provisions relating to small companies within Part 15 of the Companies Act 2006.

On behalf of the board

___________________________

Mr Qamar Zaman

Director

___________________________

Mr Kamran Khatana

Director

24 September 2025

INDEPENDENT AUDITOR'S REPORT

to the Shareholders of CONCISE MEDICO LIMITED

Report on the audit of the financial statements

Opinion

We have audited the financial statements of CONCISE MEDICO LIMITED ('the company') for the financial year ended 26 December 2024 which comprise the Profit and Loss Account, the Balance Sheet, the Statement of Changes in Equity and the related notes to the financial statements, including significant accounting policies set out in note . The financial reporting framework that has been applied in their preparation is applicable Law and United Kingdom Accounting Standards, including FRS 102 “The Financial Reporting Standard applicable in the UK and Republic of Ireland” (United Kingdom Generally Accepted Accounting Practice).

In our opinion the financial statements:
-give a true and fair view of the state of the company's affairs as at 26 December 2024 and of its profit for the financial year then ended;
-have been properly prepared in accordance with United Kingdom Generally Accepted Accounting Practice; and
-have been prepared in accordance with the requirements of the Companies Act 2006.

Basis for opinion

We conducted our audit in accordance with International Standards on Auditing (UK) (ISAs (UK)) and applicable law. Our responsibilities under those standards are further described in the Auditor's responsibilities for the audit of the financial statements section of our report. We are independent of the company in accordance with the ethical requirements that are relevant to our audit of the financial statements in the UK, including the FRC's Ethical Standard, and we have fulfilled our other ethical responsibilities in accordance with these requirements. We believe that the audit evidence we have obtained is sufficient and appropriate to provide a basis for our opinion.

Conclusions relating to going concern

In auditing the financial statements, we have concluded that the directors' use of the going concern basis of accounting in the preparation of the financial statements is appropriate.

Based on the work we have performed, we have not identified any material uncertainties relating to events or conditions that, individually or collectively, may cast significant doubt on the company's ability to continue as a going concern for a period of at least twelve months from the date when the financial statements are authorised for issue.

Our responsibilities and the responsibilities of the directors with respect to going concern are described in the relevant sections of this report.

Other Information

The other information comprises the information included in the annual report other than the financial statements and our Auditor's Report thereon. The directors are responsible for the other information contained within the annual report. Our opinion on the financial statements does not cover the other information and, except to the extent otherwise explicitly stated in our report, we do not express any form of assurance conclusion thereon.

Our responsibility is to read the other information and, in doing so, consider whether the other information is materially inconsistent with the financial statements or our knowledge obtained in the course of the audit, or otherwise appears to be materially misstated. If we identify such material inconsistencies or apparent material misstatements, we are required to determine whether this gives rise to a material misstatement in the financial statements themselves. If, based on the work we have performed, we conclude that there is a material misstatement of this other information, we are required to report that fact. We have nothing to report in this regard.

Opinion on other matters prescribed by the Companies Act 2006

In our opinion, based on the work undertaken in the course of the audit:

the information given in the Directors' Report for the financial year for which the financial statements are prepared is consistent with the financial statements; and

the Directors' Report has been prepared in accordance with applicable legal requirements.

Matters on which we are required to report by exception

In the light of our knowledge and understanding of the company and its environment obtained in the course of the audit, we have not identified any material misstatements in the Directors' Report.

We have nothing to report in respect of the following matters where the Companies Act 2006 requires us to report to you if, in our opinion:

adequate accounting records have not been kept; or

the financial statements are not in agreement with the accounting records and returns; or

certain disclosures of directors' remuneration specified by law are not made; or

we have not received all the information and explanations we require for our audit; or

the directors were not entitled to prepare the financial statements in accordance with the small companies regime and take advantage of the small companies' exemption in preparing the Directors' Report.

Responsibilities of directors for the financial statements

The directors are responsible for the preparation of the financial statements and for being satisfied that they give a true and fair view, and for such internal control as they determine is necessary to enable the preparation of financial statements that are free from material misstatement, whether due to fraud or error.

In preparing the financial statements, the directors are responsible for assessing the company's ability to continue as a going concern, disclosing, as applicable, matters related to going concern and using the going concern basis of accounting unless the directors either intend to liquidate the company or to cease operations, or has no realistic alternative but to do so.

Auditor's responsibilities for the audit of the financial statements

Our objectives are to obtain reasonable assurance about whether the financial statements as a whole are free from material misstatement, whether due to fraud or error, and to issue an Auditor's Report that includes our opinion. Reasonable assurance is a high level of assurance, but is not a guarantee that an audit conducted in accordance with ISAs (UK) will always detect a material misstatement when it exists. Misstatements can arise from fraud or error and are considered material if, individually or in the aggregate, they could reasonably be expected to influence the economic decisions of users taken on the basis of these financial statements.

Irregularities, including fraud, are instances of non-compliance with laws and regulations. We design procedures in line with our responsibilities, outlined above, to detect material misstatements in respect of irregularities, including fraud. The extent to which our procedures are capable of detecting irregularities, including fraud is detailed below:

It is your duty to ensure that Concise Medico Limited has kept adequate accounting records and to prepare
statutory financial statements that give a true and fair view of the assets, liabilities, financial position and profit of
Concise Medico Limited. You consider that Concise Medico Limited is exempt from the statutory audit requirement
for the year.

A further description of our responsibilities for the audit of the financial statements is located on the Financial Reporting Council's website at: <www.frc.org.uk/auditorsresponsibilities>. This description forms part of our Auditor's Report.

STERLING COOPER CONSULTANTS LTD

Kings Court 33 King Street

Lancashire

BB2 2DH

United Kingdom

24 September 2025

CONCISE MEDICO LIMITED

PROFIT AND LOSS ACCOUNT

for the financial year ended 26 December 2024

	2024	2023
Notes	£	£

Turnover	3	307,454	435,359

Cost of sales		(45,595)	(60,656)
		─────────	─────────
Gross profit		261,859	374,703

Administrative expenses		(162,935)	(155,907)
		─────────	─────────
Operating profit	4	98,924	218,796

Interest receivable and similar income	5	23	2
Interest payable and similar charges	6	-	(588)
		─────────	─────────
Profit on ordinary activities before taxation		98,947	218,210

Tax on profit on ordinary activities	8	(22,233)	(50,929)
		─────────	─────────
Profit for the financial year		76,714	167,281
		─────────	─────────
Total comprehensive income		76,714	167,281
		═════════	═════════

CONCISE MEDICO LIMITED

Company Registration Number: 08321341

BALANCE SHEET

as at 26 December 2024

		2024	2023
	Notes	£	£

Fixed Assets

Tangible assets

526

712

─────────

Current Assets

Debtors

133,290

103,599

Cash and cash equivalents

25,979

18,277

─────────

159,269

121,876

─────────

Creditors: amounts falling due within one year

(142,981)

(122,488)

─────────

Net Current Assets/(Liabilities)

16,288

(612)

─────────

Total Assets less Current Liabilities

16,814

100

═════════

Capital and Reserves

Called up share capital

100

100

Retained earnings

16,714

─────────

Equity attributable to owners of the company

16,814

100

═════════

These financial statements have been prepared in accordance with the special provisions relating to small companies within Part 15 of the Companies Act 2006.

Approved by the Board and authorised for issue on 24 September 2025 and signed on its behalf by

________________________________

Mr Qamar Zaman

Director

________________________________

Mr Kamran Khatana

Director

CONCISE MEDICO LIMITED

STATEMENT OF CHANGES IN EQUITY

as at 26 December 2024

	Called up	Retained	Total
	share	earnings
	capital
	£	£	£

At 27 December 2022	-	-	-
	─────────	─────────	─────────
Profit for the financial year	-	167,281	167,281
	─────────	─────────	─────────
Payment of dividends	-	(167,281)	(167,281)
	─────────	─────────	─────────
At 26 December 2023	100	-	100
	─────────	─────────	─────────
Profit for the financial year	-	76,714	76,714
	─────────	─────────	─────────
Payment of dividends	-	(60,000)	(60,000)
	─────────	─────────	─────────
At 26 December 2024	100	16,714	16,814
	═════════	═════════	═════════

CONCISE MEDICO LIMITED

NOTES TO THE FINANCIAL STATEMENTS

for the financial year ended 26 December 2024

General Information

CONCISE MEDICO LIMITED is a company limited by shares incorporated and registered in the United Kingdom. The registered number of the company is 08321341. The registered office of the company is Daisyfield Mill Appleby Street, Blackburn, Lancashire, BB1 3BL, United Kingdom which is also the principal place of business of the company. The principal activity of the company during the year continued to be the provision of legal services. The financial statements have been presented in Pound (£) which is also the functional currency of the company.

Summary of Significant Accounting Policies

The following accounting policies have been applied consistently in dealing with items which are considered material in relation to the company's financial statements.

Statement of compliance

The financial statements of the company for the financial year ended 26 December 2024 have been prepared in accordance with the Financial Reporting Standard applicable in the United Kingdom and the Republic of Ireland (FRS 102) issued by the Financial Reporting Council and in accordance with the Companies Act 2006.

Basis of preparation

The financial statements have been prepared on the going concern basis and in accordance with the historical cost convention except for certain properties and financial instruments that are measured at revalued amounts or fair values, as explained in the accounting policies below. Historical cost is generally based on the fair value of the consideration given in exchange for assets.

Cash flow statement

The company has availed of the exemption in FRS 102 from the requirement to prepare a Statement of Cash Flows because it is classified as a small company.

Turnover

Turnover comprises the invoice value of goods supplied by the company, exclusive of trade discounts and value added tax.

Tangible assets and depreciation

Tangible assets are stated at cost or at valuation, less accumulated depreciation. The charge to depreciation is calculated to write off the original cost or valuation of tangible assets, less their estimated residual value, over their expected useful lives as follows:

Fixtures, fittings and equipment

Fixtures & Fittings 25% Reducing Balance IT Equipment's 33% Straight Line

The carrying values of tangible fixed assets are reviewed annually for impairment in periods if events or changes in circumstances indicate the carrying value may not be recoverable.

Trade and other debtors

Trade and other debtors are initially recognised at fair value and thereafter stated at amortised cost using the effective interest method less impairment losses for bad and doubtful debts except where the effect of discounting would be immaterial. In such cases the receivables are stated at cost less impairment losses for bad and doubtful debts.

Borrowing costs

Borrowing costs relating to the acquisition of assets are capitalised at the appropriate rate by adding them to the cost of assets being acquired. Investment income earned on the temporary investment of specific borrowings pending their expenditure on the assets is deducted from the borrowing costs eligible for capitalisation. All other borrowing costs are recognised in profit or loss in the period in which they are incurred.

Trade and other creditors

Trade and other creditors are initially recognised at fair value and thereafter stated at amortised cost using the effective interest rate method, unless the effect of discounting would be immaterial, in which case they are stated at cost.

Employee benefits

The company operates a defined contribution pension scheme. The assets of the scheme are held separately from those of the company in an independently administered fund. The company also operates a defined benefit pension scheme for its employees providing benefits based on final pensionable pay. The assets of this scheme are also held separately from those of the company, being invested with pension fund managers.

Taxation

Current tax represents the amount expected to be paid or recovered in respect of taxable profits for the financial year and is calculated using the tax rates and laws that have been enacted or substantially enacted at the Balance Sheet date.

Foreign currencies

Monetary assets and liabilities denominated in foreign currencies are translated at the rates of exchange ruling at the Balance Sheet date. Non-monetary items that are measured in terms of historical cost in a foreign currency are translated at the rates of exchange ruling at the date of the transaction. Non-monetary items that are measured at fair value in a foreign currency are translated using the exchange rates at the date when the fair value was determined. The resulting exchange differences are dealt with in the Profit and Loss Account.

Ordinary share capital

The ordinary share capital of the company is presented as equity.

Turnover

Turnover is recognised at the fair value of the consideration received or receivable for goods and services
provided in the normal course of business, and is shown net of VAT and other sales related taxes. The fair
value of consideration takes into account trade discounts, settlement discounts and volume rebates. Turnover is recognised at the fair value of the consideration received or receivable for goods and services provided in the normal course of business, and is shown net of VAT and other sales related taxes. The fair value of consideration takes into account trade discounts, settlement discounts and volume rebates.


4.	Operating profit	2024	2023
		£	£
	Operating profit is stated after charging:
	Depreciation of tangible assets	186	607
		═════════	═════════


5.	Interest receivable and similar income	2024	2023
		£	£

	Bank interest	23	2
		═════════	═════════


6.	Interest payable and similar charges	2024	2023
		£	£

	Interest on overdue tax	-	588
		═════════	═════════

Employees

The average monthly number of employees, including directors, during the financial year was 3, (2023 - 7).

Tax on profit on ordinary activities

2024

2023

(a) Analysis of charge in the financial year

Current tax:

Corporation tax at 22.70% (2023 - 25.00%) (Note 8 (b))

22,233

50,929

═════════

(b) Factors affecting tax charge for the financial year

The tax assessed for the financial year differs from the standard rate of corporation tax in United Kingdom 22.70% (2023 - 25.00%). The differences are explained below:

2024

2023

Profit taxable at 22.70%

98,947

218,210

═════════

Profit on ordinary activities before tax

multiplied by the standard rate of corporation tax

in United Kingdom at 22.70% (2023 - 25.00%)

22,461

54,553

Effects of:

Expenses not deductible for tax purposes

(228)

(3,624)

─────────

Total tax charge for the financial year (Note 8 (a))

22,233

50,929

═════════


9.	Dividends	2024	2023
		£	£
	Dividends on equity shares:

	Ordinary - Final paid	60,000	167,281
		═════════	═════════


10.	Tangible assets
		Fixtures,	Total
		fittings and
		equipment
		£	£
	Cost
	At 27 December 2023	32,159	32,159
		─────────	─────────

	At 26 December 2024	32,159	32,159
		─────────	─────────
	Depreciation
	At 27 December 2023	31,447	31,447
	Charge for the financial year	186	186
		─────────	─────────
	At 26 December 2024	31,633	31,633
		─────────	─────────
	Net book value
	At 26 December 2024	526	526
		═════════	═════════
	At 26 December 2023	712	712
		═════════	═════════


11.	Debtors	2024	2023
		£	£

	Other debtors	115,587	86,748
	Directors' current accounts (Note 16)	17,703	16,851
		─────────	─────────
		133,290	103,599
		═════════	═════════


12.	Creditors	2024	2023
	Amounts falling due within one year	£	£

	Pension fund loan	-	(241)
	Taxation (Note 13)	78,586	60,381
	Other creditors	40,470	9,516
	Accruals	23,925	52,832
		─────────	─────────
		142,981	122,488
		═════════	═════════


13.	Taxation	2024	2023
		£	£

	Creditors:
	VAT	7,128	1,327
	Corporation tax	70,457	58,294
	PAYE / NI	1,001	760
		─────────	─────────
		78,586	60,381
		═════════	═════════


14.	Share capital			2024	2023
				£	£
	Description	Number of shares	Value of units

	Allotted, called up and fully paid
	Ordinary	100	£1.00 each	100	100

				═════════	═════════

15.

Capital commitments

The company had no material capital commitments at the financial year-ended 26 December 2024.


16.	Directors' remuneration and transactions	2024	2023
		£	£

	Directors' remuneration
	Remuneration	-	20,513
		═════════	═════════

The following advances were made to the directors:

Balance at

Movement

Balance at

Maximum

26/12/24

in year

26/12/23

in year

Mr Qamar Zaman

17,703

852

16,851

═════════

17.

Post-Balance Sheet Events

There have been no significant events affecting the company since the financial year-end.